Search companies or stocks...
PSTVPlus Therapeutics, Inc.
At close · 31 July 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and…
Current stock price of Plus Therapeutics, Inc. (PSTV) stock is $3.870. The stock price is -3.25% lower in the session. The intraday range can be seen from this page. Volume of Plus Therapeutics, Inc. (PSTV) stock is 96.53K.
Last updated at 31 July 2026, 08:00 pm.
The stock price of Plus Therapeutics, Inc. (PSTV) can change with earnings, company news, and overall market sentiment. Plus Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Plus Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PSTV on this page is -2.00. EPS on this page is -1.93. Compare those figures with peers and growth expectations before deciding if the current Plus Therapeutics, Inc. price is justified.
Historical performance for Plus Therapeutics, Inc. (PSTV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PSTV reacted to past earnings and market events.
Buying Plus Therapeutics, Inc. (PSTV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
